Biogen Idec (BIIB): Rega marang bathi kanthi panyesuaian wutah
Biogen Inc. combines strict environmental responsibility with premium pricing for exclusive drugs treating rare pathologies. The balanced price-to-earnings to growth ratio on the GURU.Markets terminal chart reflects current dynamics, where 2.48 expresses today's metric value. The business is currently undergoing a portfolio refresh, anticipating the commercial success of new medications to overcome a cyclical downturn.
Biogen Inc. (BIIB) - rincian metrik lan laporan keuangan
- rega lan prakiraan konsensus rega:
- data kapitalisasi bursa:
- data nilai buku modal saham:
- statistik kawajiban utang lan likuiditas:
Rasio Utang marang Ekuitas Biogen Inc.|BIIB - Rasio utang jangka dawa marang ekuitas|Rasio tanggungan utang jangka cendhak marang modal biogen.com|BIIB - Gunggung utang perusahaan|Utang-utang marang aset resik Biogen Corp|BIIB - Utang jangka dawa perusahaan|Tanggungan utang jangka cendhak perusahaan Biogen|Indikator likuiditas cepet biogen.com
- rincian bathi lan kelipatan pasar:
BIIB - Penghasilan resik|Prakiraan bathi perusahaan Biogen Inc.|BIIB - Pangali P/E|Rega marang bathi mangsa ngarep Biogen Idec|BIIB - Pangali PEG|Rasio total nilai perusahaan marang bathi operasional sadurunge panyusutan Biogen Corp|BIIB - Bathi operasional EBITDA|Bathi resik saben saham sajrone patang kuartal pungkasan Biogen|BIIB - Bathi resik saben saham (EPS TTM)|Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan biogen.com|BIIB - Wutah bathi saben saham ing taun lumaku|Proyeksi kacepetan wutah bathi saben saham kanggo taun ngarep Biogen Inc.
Analisis umum perusahaan:BIIB, Biogen Inc
High promotion costs for new Alzheimer's treatments, coupled with the stagnation of legacy products, are limiting the current margins of Biogen Inc. (BIIB). This under-valuation indicator relative to growth compares the P/E multiple with earnings growth rates, determining whether the business expansion dynamics justify the current market value of the shares or if the asset is trading at a discount to its potential.
Pesaing Biogen Inc.
Kapitalisasi marang bathi resik kanthi nimbang wutah Neurocrine|Rasio rega marang bathi tumrap wutah Regencell RGC|Axsome Corp (AXSM) - Rega marang bathi kanthi panyesuaian wutah|ACADIA Pharmaceuticals - Pangali PEG|Rasio rega marang wutah bathi resik xenon-pharma.com (XENE)|VKTX: Pangali PEG|Rega marang bathi kanthi panyesuaian wutah Supernus Pharmaceuticals, Inc. (SUPN)|Rasio rega marang bathi tumrap wutah Catalyst Pharmaceuticals Inc|Rasio P/E diaturake wutah DNLI (Denali Corp)|Pangali rega marang bathi tumrap wutah HRMY (Harmony Biosciences)|BHVN (biohavenpharma.com) - Koefisien bali modal nimbang wutah|Pangali PEG AMLX (Amylyx Pharmaceuticals, Inc.)|Kapitalisasi marang bathi resik kanthi nimbang wutah Trevi Therapeutics Inc (TRVI)|PRAX - Rasio rega marang bathi tumrap wutah|AVXL (Anavex Life Sciences Corp) - Rasio P/E diaturake wutah|CBLL: Pangali PEG|Pangali rega marang bathi tumrap wutah Prothena|Pangali rega marang bathi tumrap wutah ALEC|Annexon Biosciences (ANNX) - Kapitalisasi marang bathi resik kanthi nimbang wutah|Pangali PEG OMER|Rasio rega marang bathi tumrap wutah NGNE (Neurogene Therapeutics)|Pangali PEG ACIU (AC Immune)|Kapitalisasi marang bathi resik kanthi nimbang wutah voyagertherapeutics.com (VYGR)|Neumora Therapeutics, Inc. - Pangali PEG|Kapitalisasi marang bathi resik kanthi nimbang wutah Scilex Holding SCLX|TVGN: Pangali PEG|ACOG (Alpha Cognition Inc.) - Rasio rega marang bathi tumrap wutah|Rasio rega marang bathi tumrap wutah Cognition Therapeutics|Rasio P/E diaturake wutah IKT (inhibikase.com)|Pangali PEG SAVA|ASRT - Rega marang bathi kanthi panyesuaian wutah|Coya Therapeutics - Pangali rega marang bathi tumrap wutah|Pangali PEG VistaGen Therapeutics, Inc. VTGN|OVID - Rasio rega marang bathi tumrap wutah|Koefisien bali modal nimbang wutah ABOS (acumenpharm.com)|CervoMed (CRVO) - Rasio rega marang bathi tumrap wutah|Rega marang bathi kanthi panyesuaian wutah Alterity Therapeutics Limited (ATHE)|CLNN (Clene Inc) - Pangali PEG|Rasio rega marang bathi tumrap wutah PEPG|Pangali PEG JUNS|Kapitalisasi marang bathi resik kanthi nimbang wutah relmada.com|Rasio rega marang bathi tumrap wutah Annovis Bio ANVS|Grace Therapeutics Inc (GRCE) - Rega marang bathi kanthi panyesuaian wutah|Firefly Neuroscience Inc - Pangali PEG|Rasio rega marang wutah bathi resik Klotho Neurosciences Inc (KLTO)|NRSN: Pangali PEG|Rega marang bathi kanthi panyesuaian wutah revivapharma.com (RVPH)|Rasio rega marang bathi tumrap wutah MetaVia Inc.|Rasio P/E diaturake wutah NRXS (NeurAxis Inc.)|Pangali rega marang bathi tumrap wutah HSDT (Helius Medical)|PASG (passagebio.com) - Koefisien bali modal nimbang wutah|Pangali PEG NEUP (Neuphoria Therapeutics)|Kapitalisasi marang bathi resik kanthi nimbang wutah minervaneurosciences.com (NERV)|ATHA - Rasio rega marang bathi tumrap wutah|ADXN (Addex Therapeutics Ltd.) - Rasio P/E diaturake wutah|ALZN: Pangali PEG|Pangali rega marang bathi tumrap wutah Cyclerion Therapeutics, Inc.|Pangali rega marang bathi tumrap wutah PTIX|Pasithea (KTTA) - Kapitalisasi marang bathi resik kanthi nimbang wutah|Pangali PEG CRGT|Rasio rega marang bathi tumrap wutah ATXI (Avenue Therapeutics Inc.)|Pangali PEG BCLI (Brainstorm Cell Therapeutics, Inc.)|Kapitalisasi marang bathi resik kanthi nimbang wutah Cara Therapeutics Inc (CARA)|Chromocell Therapeutics - Pangali PEG|Kapitalisasi marang bathi resik kanthi nimbang wutah Eliem Therapeutics ELYM|ITCI: Pangali PEG|LBPH (Longboard Pharmaceuticals Inc) - Rasio rega marang bathi tumrap wutah|Rasio rega marang bathi tumrap wutah Marinus|Rasio P/E diaturake wutah NKGN (NKGen Biotech Corp)|Pangali PEG NRBO|SAGE - Rega marang bathi kanthi panyesuaian wutah|Synaptogenix - Pangali rega marang bathi tumrap wutah|Pangali PEG Trevena Inc. TRVN|VIGL - Rasio rega marang bathi tumrap wutah|Koefisien bali modal nimbang wutah WENA (Anew Medical Inc.)|Cerevel Therapeutics (CERE) - Rasio rega marang bathi tumrap wutah
